Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03162822 · ClinicalTrials.gov registry record · NA

Caregiver-Child Interaction and Health Behaviors

A NA study, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
158
Enrollment target

NCT03162822: Completed NA study, sponsored by NYU Langone Health.

NCT03162822 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 158 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03162822, a NA study, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
158 participants
Enrollment target

Study Summary

Caregivers and their child are being asked to participate because the investigators are interested in typical caregiver-child interactions and health behaviors. In particular, the investigators are interested in different ways that caregivers react to and understand their young children's behavior, and their health behaviors.

Primary Outcome

The subject runners will have caregivers and their child complete a series of tasks that are the sorts of activities they might encounter in daily life. In the first task the subject runners will have caregivers direct their child to clean up toys. In the second task the subject runners will have their child play with some toys while they are occupied on their phone. In the third task the subject runners will give them questionnaires to complete while their child waits on a mat.

Interventions

  • BEHAVIORAL Behavioral Intervention
  • OTHER Cognitive Intervention
  • OTHER Interpretation Bias Intervention
  • OTHER Evaluative Conditioning

Trial Details

FieldValue
Enrollment Target 158 participants
Start Date 2017-05-01
Est. Completion 2020-06-30
Phase NA
NYU Langone Health

1,164 total trials

What the finished NCT03162822 record still lists

NCT03162822 is an interventional study that assigns participants to a tested intervention. The registered 158 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).

The record links to 0 conditions, and to 4 interventions - of which Behavioral Intervention is the first listed.

NCT03162822 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03162822 about?

NCT03162822 is a clinical study titled "Caregiver-Child Interaction and Health Behaviors". Caregivers and their child are being asked to participate because the investigators are interested in typical caregiver-child interactions and health behaviors. In particular, the investigators are interested in different ways that caregivers react to and understand their young children's behavior, ...

What is the current status of trial NCT03162822?

This trial is currently completed. It is a NA study. The enrollment target is 158 participants. The study started on 2017-05-01. Estimated completion is 2020-06-30.

What interventions are being tested in trial NCT03162822?

The interventions under investigation include: Behavioral Intervention (BEHAVIORAL), Cognitive Intervention (OTHER), Interpretation Bias Intervention (OTHER), Evaluative Conditioning (OTHER).

Who is sponsoring clinical trial NCT03162822?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03162822's enrollment target sits among peer trials

158 654th of 2000 higher than 1,345 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04486833 · 158 participants · Phase 1

    Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib

  • NCT04697966 · 158 participants · NA

    Mechanisms and Predictors of Change in App-Based Mindfulness Training for Adolescents

  • NCT04969835 · 158 participants · Phase 1

    A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours

  • NCT05230732 · 158 participants · NA

    Neuromodulation of Inflammation and Endothelial Function

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03162822, the US trial registry maintained by the National Library of Medicine. NCT03162822 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.